Boston, Massachusetts–(Newsfile Corp. – May 15, 2025) – Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, presented preclinical data demonstrating the potential of its tRNA therapy in Duchenne Muscular Dystrophy (DMD). The study showed that Tevard’s suppressor tRNA rescued …
Read More »Stonegate Capital Partners Updates Coverage on Surf Air Mobility Inc. (SRFM) 2025 Q1
Dallas, Texas–(Newsfile Corp. – May 15, 2025) – Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners updates their coverage on Surf Air Mobility Inc. (NYSE: SRFM). SRFM reported revenue, adj EBITDA, and adj EPS of $23.5M, ($14.4)M, and ($1.09), respectively. It is notable that the Company was well within …
Read More »Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial
Halifax, Nova Scotia–(Newsfile Corp. – May 15, 2025) – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company”, “Sona”) is pleased to announce the successful completion of bacterial endotoxin testing (“BET”) on Sona’s uniquely biocompatible gold nanorods using the Limulus Amebocyte Lysate (“LAL”) method at a leading global provider of …
Read More »Turnium Technology Group Secures Two Additional Renewable Network Projects Exceeding C$504K with Global Power Generation Australia
GPG Australia becomes one of Claratti’s Top 10 Global Customers Vancouver, British Columbia–(Newsfile Corp. – May 15, 2025) – Turnium Technology Group Inc. (TSXV: TTGI) (FSE: E48) (“Turnium” or “the Company”), a global leader in Technology-as-a-Service (TaaS) and partner enablement services, including an AI-powered prospecting and lead generation platform, is …
Read More »WonderFi Reports First Quarter 2025 Results
Achieved $17.5 million in revenue and interest income during the quarter ended March 31st. Wholly owned trading platforms Bitbuy and Coinsquare generated over $1.128 billion in trading volumes during the quarter. Toronto, Ontario–(Newsfile Corp. – May 15, 2025) – WonderFi Technologies Inc. (TSX: WNDR) (OTCQB: WONDF) (WKN: A3C166) (“WonderFi” or …
Read More »MTB Metals to Focus on its Telegraph Copper-Gold Porphyry and Sell Certain Non-Core Assets
MTB to sell interests in four non-core exploration projects, preserving upside by retaining royalty interests. Strengthened balance sheet will help advance its Telegraph copper-gold porphyry project. Focus will be on advancing the multiple porphyry copper-gold targets identified at Telegraph. Several majors are showing interest in this project, located in British …
Read More »Ridgeline Minerals Provides Drill Program Updates for the Big Blue and Atlas Projects
Vancouver, British Columbia–(Newsfile Corp. – May 15, 2025) – Ridgeline Minerals Corp. (TSXV: RDG) (OTCQB: RDGMF) (FSE: 0GC0) (“Ridgeline” or the “Company”) is pleased to provide updates for maiden drill programs at the Big Blue and Atlas exploration projects. Both projects are 100%-owned by the Company with no underlying work …
Read More »BTCS Reports Q1 2025 Results
Silver Spring, Maryland–(Newsfile Corp. – May 15, 2025) – BTCS Inc. (NASDAQ: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, announced its financial results for the three months ended March 31, 2025 (“Q1 2025”). Q1 2025 Financial Highlights Revenue: $1.7 million, up 274% from $0.5 million …
Read More »Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5
Singapore, Singapore–(Newsfile Corp. – May 15, 2025) – Mobile-health Network Solutions (NASDAQ: MNDR) (“MNDR” or “the Company”), a leading MedTech innovator ranked among Asia-Pacific’s high-growth companies, today announced it will present at two upcoming conferences. Co-CEOs and co-founders Dr. Tung Yeng Siaw and Dr. Rachel Teoh will present and host …
Read More »European Hematology Association Accepts Abstract from Telo Genomics for Presentation at The 2025 Congress
Toronto, Ontario–(Newsfile Corp. – May 15, 2025) – Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, today announced that the European Hematology Association (“EHA”) has accepted Telo Genomics’ …
Read More »
Matribhumi Samachar English